Quingestanol acetate
From Wikipedia, the free encyclopedia
Jump to: navigation, search
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| Synonyms | W-4540 |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ECHA InfoCard | 100.019.163 |
| Chemical and physical data | |
| Formula | C27H36O3 |
| Molar mass | 408.573 g/mol |
| 3D model (JSmol) | |
|
|
|
|
Quingestanol acetate (INN, USAN) (brand names Demovis, Pilomin, Riglovis, Unovis), also known as norethisterone acetate 3-cyclopentyl enol ether, is a steroidal progestin of the 19-nortestosterone group with additional weak androgenic and estrogenic activity which is used as an oral, once-a-month, or postcoital hormonal contraceptive.[1][2][3][4] It is a prodrug of norethisterone, with both quingestanol and norethisterone acetate serving as intermediates in the transformation.[5][6] The drug was patented in 1963[7] and marketed in Italy in 1972.[8][9]
See also[edit]
References[edit]
- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1058–. ISBN 978-1-4757-2085-3.
- ^ Giannina T, Steinetz BG, Rassaert CL, McDougall EA, Meli A (July 1969). "Biological profile of quingestanol acetate". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 131 (3): 781–9. PMID 5815452. doi:10.3181/00379727-131-33977.
- ^ Mischler TW, Rubio B, Larranaga A, Guiloff E, Moggia AV (March 1974). "Further experience with quingestanol acetate as a postcoital oral contraceptive". Contraception. 9 (3): 221–5. PMID 4613534. doi:10.1016/0010-7824(74)90013-4.
- ^ Donde UM, Virkar KD (June 1975). "Biochemical studies with once-a-month contraceptive pill containing quinestrol-quingestanol acetate". Contraception. 11 (6): 681–8. PMID 1137940. doi:10.1016/0010-7824(75)90065-7.
- ^ Raynaud JP, Ojasoo T (1986). "The design and use of sex-steroid antagonists". J. Steroid Biochem. 25 (5B): 811–33. PMID 3543501.
Similar androgenic potential is inherent to norethisterone and its prodrugs (norethisterone acetate, ethynodiol diacetate, lynestrenol, norethynodrel, quingestanol).
- ^ Di Carlo FJ, Loo JC, Aceto T, Zuleski FR, Barr WH (1974). "Quingestanol acetate metabolism in women". Pharmacology. 11 (5): 287–303. PMID 4853997. doi:10.1159/000136501.
- ^ Lara Marks (2010). Sexual Chemistry: A History of the Contraceptive Pill. Yale University Press. pp. 73–. ISBN 978-0-300-16791-7.
- ^ Population Reports: Oral contraceptives. Department of Medical and Public Affairs, George Washington Univ. Medical Center. 1975. p. A-64.
- ^ Janne S. Kowalski (1 August 1988). Drug companies & products world guide. Sittig & Noyes. p. 388.
| Androgens (incl. AAS) |
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antiandrogens |
|
||||||||||||
|
|||||||||||||
| Estrogens |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antiestrogens |
|
||||||||
|
|||||||||
| AR |
|
||||||
|---|---|---|---|---|---|---|---|
| GPRC6A |
|
||||||
| PR |
|
||||||
|---|---|---|---|---|---|---|---|
| mPR (PAQR) |
|
||||||
| ER |
|
||||||
|---|---|---|---|---|---|---|---|
| GPER |
|
||||||
| This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
| This article about a steroid is a stub. You can help Wikipedia by expanding it. |